Takeda UK has appointed Craig Adkins as its new business unit director for irritable bowel disease (IBD).
Adkins joins the senior leadership team having spent 18 months in the Zurich office leading many strategic projects across the Europe and Canada region alongside European senior leadership.
Adkins has almost 20 years of experience working in the pharma industry, with a long history at Takeda having joined in 2005 as a regional account director.
One of Adkins most notable successes has been the leadership of a successful repatriation, resulting in a doubled market share and growth on a mature brand.
Commenting on the recent appointment, Yasuhiro Fukutomi, managing director, Takeda UK, says: “We are delighted to have Craig back in the UK and joining the senior leadership team.
“He brings with him a wealth of invaluable international experience to complement the expertise of our existing senior leadership team and we have no doubt that his experience and ability to lead teams will see him deliver the same success he has achieved in the past.”